January 17, 2019 at 1:04 pm

Corporate Owners Directed Efforts to Mislead Doctors and Patients about Product Risks

Efforts to mislead doctors and patients about the dangers of Purdue Pharma’s opioid product came from the top, alleges new court filing. See:┬ánytimes.com/2019/01/15/health/sacklers-purdue-oxycontin-opioids.html